Hungarian pharmaceutical group Gedeon Richter posted sales worth 145.7 million dollars (106 million euros) on the local market in 2006, through its three divisions, production, distribution and import, according to the company's annual report. The consolidated operating profit of the Richter group went down by 25.2%, given the provisions it had set up in Russia and Romania, while the consolidated net income was affected by the depreciation of the RON against the euro. In Romania, Richter Gedeon owns the Gedeon Richter Romania drug plant in Targu-Mures (a branch which manages drugs imported from Hungary), retail company Gedeon Richter Farmacia, the Dita group (involved in drug distribution), as well as a strategic development company, Armedica Trading. The production facility in Targu-Mures, Gedeon Richter Romania, posted sales worth 25.8 million dollars last year, up by 25.9% against the 20.5 million dollars witnessed in 2006. During the same interval, sales of the Hungarian group from the distribution of pharmaceutical products on the Romanian market climbed to 102 million dollars.
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
